Upgrade to SI Premium - Free Trial

Genentech presents new giredestrant breast cancer data at ASCO 2026

May 19, 2026 1:05 AM
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), will present data from nine approved and investigational ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA